Drug-Eluting Stent Penetration Lowest in Arkansas, Outnumbered by Bare-Metal Stents
Posted on: Monday, 21 September 2009, 07:07 CDT
WALTHAM, Mass., Sept. 21 /PRNewswire/ -- Millennium Research Group (MRG) the global authority on medical technology market intelligence, finds that Arkansas has the lowest coronary drug-eluting stent (DES) penetration rate in the US at 49%, followed closely by Montana, Utah, and South Dakota. These numbers contrast the national picture, in which DES represent an overwhelming 70% of coronary stent procedure volumes and, due to their high price premium, 84% of coronary stent revenues.
The penetration of DES at the hospital level depends heavily on hospital profile, according to MRG's new analytics tool, Procedure Finder: Interventional Cardiology. Urban hospitals, which are more likely to have elevated bed counts, budgets, and patient volumes, are more likely to use premium-priced DES in their coronary stenting procedures. In contrast, rural hospitals with smaller bed counts, tighter budgets, and lower patient volumes are more likely to use bare metal stents (BMS), if they perform coronary stenting procedures at all. Nowhere is this more evident than in Arkansas, where BMS are used in an overwhelming 64% of cases performed in rural hospitals (compared to 35% nationally).
"There are only five rural facilities performing coronary stenting procedures in Arkansas and the busiest of those -- White River Medical Center in Batesville -- uses BMS almost exclusively," says Aaron Dickson, Co-President of MRG. "Similarly, the state's largest stenting facility -- the Arkansas Heart Hospital in Little Rock -- performs nearly 4,000 stenting procedures annually and is using DES in less than 20% of them." The relatively low urbanization of the state is likely affecting even those facilities located in urban areas, leading to low overall DES penetration in the state compared to more densely populated regions.
About Procedure Finder
Procedure Finder is Millennium Research Group's new facility level procedural forecasting tool. This database allows health care sales and marketing managers to identify and analyze all hospitals that are performing specific procedures of interest. Procedure Finder provides data points such as:
- Procedure volume forecasts by setting (inpatient vs. outpatient)
- Procedure volume forecasts by payer type (Medicare, Medicaid, private, and uninsured)
- Hospital demographics, including total revenue, discharges, patient days, bed count, and catchment area
Using this data, companies can:
- Align sales and marketing activities around areas with the most potential
- Gauge sales force effectiveness
- Benchmark performance in different regions
- Better define sales territories to maximize share in high-profit areas
- Identify regional variances in health care provision
- Forecast relevant device and procedure markets through 2013
About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact: Amy Krohn Millennium Research Group 416-364-7776 x101 akrohn@mrg.net Elizabeth Marshall Decision Resources Inc. 781-296-2563 emarshall@dresources.comSOURCE Millennium Research Group
Source: PR Newswire
Related Articles
- Despite Limitations the Asia Pacific Spinal Nonfusion Market Will See Double-Digit Growth Through 2013, According to Millennium Research Group
- Many Dental Companies Use Digital Dentistry to Bolster Recession-Bruised Revenues, According to Millennium Research Group
- Recent EMEA Regulations to Drive Autologous Chondrocyte Implantation Procedures Through 2013, According to Millennium Research Group
- Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group
- Broncus Technologies' Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market, According to Millennium Research Group
- Screening Programs to Drive European GI Videoscope Market Despite Economic Downturn, According to Millennium Research Group
- Millennium Research Group's New Perception Pulse Product Offers Clients an Innovative New Customer Behavior and Loyalty Tracking Tool
- Although the Health Care Market is Recession-Resistant, It Is Not Recession-Immune, According to Millennium Research Group's Medtech Economic Quarterly Publication
- US Spinal Nonfusion Procedures Set to Increase Nearly Five Times From 2008 to 2013, According to Millennium Research Group
- /C O R R E C T I O N -- Millennium Research Group/
 |
 |
User Comments (0)
RSS Feeds